Concepedia

Joel Sampedro

JS

8

Publications

347

Citations

8

H-Index

2017

Active since

Affiliations

Instituto de Salud Carlos III(Current)

Vall d'Hebron Institut de Recerca

Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas

Universitat Autònoma de Barcelona

Vifor Pharma (Switzerland)

Joel Sampedro is an author at Instituto de Salud Carlos III specializing in medicine, diabetes, and ophthalmology.

ORCID

Top concepts

Publications per year

2017–2020

8

Publications

8

Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes

Cristina Hernández, Patricia Bogdanov, Cristina Solà-Adell et al. · Diabetologia · 2017 · 91 citations · Full text

, , +10

New Insights into the Mechanisms of Action of Topical Administration of GLP-1 in an Experimental Model of Diabetic Retinopathy

Joel Sampedro, Patricia Bogdanov, Hugo Ramos et al. · Journal of Clinical Medicine · 2019 · 49 citations · Full text

, , +23

Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative Stress

Hugo Ramos, Patricia Bogdanov, Joel Sampedro et al. · Antioxidants · 2020 · 42 citations · Full text

Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes

Cristina Solà-Adell, Patricia Bogdanov, Cristina Hernández et al. · Current Eye Research · 2017 · 36 citations · Full text

Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration

Patricia Bogdanov, Joel Sampedro, Cristina Solà-Adell et al. · International Journal of Molecular Sciences · 2018 · 36 citations · Full text

, , +21

Rows per page

1–5 of 8